CAS No. 639523-07-2

2-Pyrimidinamine,N-cyclohexyl-4-methyl-6-[2-[[5-[(4-methyl-1-piperazinyl)methyl]pyrazinyl]amino]-5-thiazolyl]-

Quinoline, 2-(3,3-diethoxy-1-propynyl)-

Pyrazinamine,N-[5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-thiazolyl]-5-[[3-(dimethylamino)-1-pyrrolidinyl]methyl]-

BENZOXAZOLIUM,5-PHENYL-2-[2-[[5-PHENYL-3-(3-SULFOPROPYL)-2(3H)-BENZOXAZOLYLIDENE]METHYL]-1-BUTENYL]-3-(3-SULFOPROPYL)-,INNER SALT,POTASSIUM SALT

Pyrazinamine,N-[5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-thiazolyl]-5-[(4-methyl-1-piperazinyl)methyl]-, trifluoroacetate

(4,4-DIFLUOROCYCLOHEXYL)METHYL METHANESULFONATE

194427-24-2

Cyclohexanone, 2-[2-(phenylmethoxy)ethoxy]-

Pyrazinamine,N-[5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-thiazolyl]-5-[[4-(phenylmethyl)-1-piperidinyl]methyl]-, trifluoroacetate

Piperazine, 1-[2-(2-fluorophenyl)ethyl]-

5-(Benzyloxy)-4-fluoro-1H-pyrrolo[2,3-b]pyridine

Cyclopropanecarboxamide,N-[6-[[[(Z)-[(4-chlorophenyl)(1-methyl-1H-tetrazol-5-yl)methylene]amino]oxy]methyl]-2-pyridinyl]-

Propaneselenoic acid, 2-methyl-, sodium salt

135249-88-6

Cyclohexanone, 4,4'-(1,2-dimethyl-1,2-ethenediyl)bis[4-methyl-, (E)-

Pyrazinamine,N-[5-[2-(cyclohexylthio)-6-methyl-4-pyrimidinyl]-2-thiazolyl]-5-[[3-(dimethylamino)-1-pyrrolidinyl]methyl]-

Benzoic acid, 2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]thio]-,methyl ester

N-cyclohexyl-N,3-diMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-aMine

2-[fluoro(methyl)phosphoryl]oxyethyl-dimethyl-phenylazanium; methylsulfate

19447-71-3

L-Valine, L-valyl-L-valyl-2-oxo-3-aminobutanoyl-D-leucyl-

4-(3-fluorophenyl)oxane-2,6-dione

L-Alanine,L-tyrosyl-L-prolyl-L-alanyl-L-leucyl-L-methionyl-L-prolyl-L-leucyl-L-tyrosyl-

1H-Indazole-3-carboxamide, N-(3S)-1-azabicyclo[2.2.2]oct-3-yl-5-nitro-

1H-Imidazol-4-ol,4,5-dihydro-1-[4-(methylsulfonyl)phenyl]-2-(3-thienyl)-4-(trifluoromethyl)-

2-(2,6-difluorophenyl)-4-methylbenzimidazole

199594-55-3

4-Octenoic acid, 2-[(diethylamino)methyl]-3-hydroxy-, methyl ester

Formic acid, compd. withN-(3S)-1-azabicyclo[2.2.2]oct-3-yl-6-methoxy-5-(3-thienyl)-1H-indazole-3-carboxamide (1:1)

1-(4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperidine-4-carboxaMide

Formic acid, compd. withN-(3S)-1-azabicyclo[2.2.2]oct-3-yl-6-(2,2,2-trifluoroethoxy)-1H-indazole-3-carboxamide (1:1)

Quinoline,4-[1-[2-(3-chlorophenyl)ethoxy]ethyl]-1,2-dihydro-6-(2-methoxyphenyl)-2,2-dimethyl-

2(3H)-Furanone, dihydro-4-(triphenylmethoxy)-, (R)-

131915-32-7

2-Methyl-2-p-tolylpropanenitrile

2-Thiophenecarboxylic acid, 4,4'-(1-cyclopentene-1,2-diyl)bis[5-methyl-

7-Oxa-1-azabicyclo[2.2.1]heptane,4,5-bis(diphenylphosphinyl)-2,2-dimethyl-, endo-

diethyl {[(1S,12bS)-1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-1-yl]methyl}propanedioate

1H-Indazole-3-carboxamide,N-(3S)-1-azabicyclo[2.2.2]oct-3-yl-1-ethyl-5-methoxy-

Tetrasilane, 1,4-dibromo-1,1,2,2,3,3,4,4-octaphenyl-

13529-76-5